{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:39:09Z","timestamp":1773391149946,"version":"3.50.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tissue inhibitors of metalloproteinase (TIMP) family proteins are peptidases involved in extracellular matrix (ECM) degradation. Various diseases are related to TIMPs, and the primary reason is that TIMPs can indirectly regulate remodelling of the ECM and cell signalling by regulating matrix metalloproteinase (MMP) activity. However, the link between TIMPs and glioblastoma (GBM) is unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>This study aimed to explore the role of TIMP expression and immune infiltration in GBM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Oncomine, GEPIA, OSgbm, LinkedOmics, STRING, GeneMANIA, Enrichr, and TIMER were used to conduct differential expression, prognosis, and immune infiltration analyses of TIMPs in GBM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All members of the TIMP family had significantly higher expression levels in GBM. High TIMP3 expression correlated with better overall survival (OS) and disease-specific survival (DSS) in GBM patients. TIMP4 was associated with a long OS in GBM patients. We found a positive relationship between TIMP3 and TIMP4, identifying gene sets with similar or opposite expression directions to those in GBM patients. TIMPs and associated genes are mainly associated with extracellular matrix organization and involve proteoglycan pathways in cancer. The expression levels of TIMPs in GBM correlate with the infiltration of various immune cells, including CD4+ T cells, macrophages, neutrophils, B cells, CD8<jats:sup>+<\/jats:sup> T cells, and dendritic cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study inspires new ideas for the role of TIMPs in GBM and provides new directions for multiple treatment modalities, including immunotherapy, in GBM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-021-02477-1","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T08:03:54Z","timestamp":1636963434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Comprehensive analysis of expression, prognosis and immune infiltration for TIMPs in glioblastoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Jinkun","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fubing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"issue":"2","key":"2477_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97\u2013109.","journal-title":"Acta Neuropathol."},{"issue":"7","key":"2477_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, et al. The epidemiology of glioma in adults: a \u201cstate of the science\u201d review. Neuro Oncol. 2014;16(7):896\u2013913.","journal-title":"Neuro Oncol."},{"issue":"5","key":"2477_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459\u201366.","journal-title":"Lancet Oncol."},{"key":"2477_CR4","doi-asserted-by":"crossref","unstructured":"Lu P, Takai K, Weaver VM, Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. 2011;3(12).","DOI":"10.1101\/cshperspect.a005058"},{"issue":"5","key":"2477_CR5","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","volume":"57","author":"BK Ahir","year":"2020","unstructured":"Ahir BK, Engelhard HH, Lakka SS. Tumor development and angiogenesis in adult brain tumor: glioblastoma. Mol Neurobiol. 2020;57(5):2461\u201378.","journal-title":"Mol Neurobiol."},{"issue":"4","key":"2477_CR6","first-page":"427","volume":"17","author":"JR Wang","year":"2013","unstructured":"Wang JR, Li XH, Gao XJ, An SC, Liu H, Liang J, et al. Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma. Eur Rev Med Pharmacol Sci. 2013;17(4):427\u201335.","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"6","key":"2477_CR7","doi-asserted-by":"publisher","first-page":"8301","DOI":"10.3892\/mmr.2017.7634","volume":"16","author":"X Cai","year":"2017","unstructured":"Cai X, Zhu H, Li Y. PKC\u03b6, MMP-2 and MMP-9 expression in lung adenocarcinoma and association with a metastatic phenotype. Mol Med Rep. 2017;16(6):8301\u20136.","journal-title":"Mol Med Rep."},{"issue":"1","key":"2477_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2009.07.014","volume":"289","author":"S Kenig","year":"2010","unstructured":"Kenig S, Alonso MB, Mueller MM, Lah TT. Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9. Cancer Lett. 2010;289(1):53\u201361.","journal-title":"Cancer Lett."},{"issue":"3-4","key":"2477_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.biochi.2005.01.014","volume":"87","author":"T Turpeenniemi-Hujanen","year":"2005","unstructured":"Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie. 2005;87(3-4):287\u201397.","journal-title":"Biochimie."},{"key":"2477_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.matbio.2015.03.005","volume":"44-46","author":"V Arpino","year":"2015","unstructured":"Arpino V, Brock M, Gill SE. The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 2015;44-46:247\u201354.","journal-title":"Matrix Biol"},{"issue":"4","key":"2477_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00018-013-1457-3","volume":"71","author":"C Ries","year":"2014","unstructured":"Ries C. Cytokine functions of TIMP-1. Cell Mol Life Sci. 2014;71(4):659\u201372.","journal-title":"Cell Mol Life Sci."},{"issue":"3","key":"2477_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.critrevonc.2003.09.008","volume":"49","author":"E Lambert","year":"2004","unstructured":"Lambert E, Dass\u00e9 E, Haye B, Petitfr\u00e8re E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol. 2004;49(3):187\u201398.","journal-title":"Crit Rev Oncol Hematol."},{"issue":"1","key":"2477_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0014-5793(96)01066-6","volume":"396","author":"K Yamashita","year":"1996","unstructured":"Yamashita K, Suzuki M, Iwata H, Koike T, Hamaguchi M, Shinagawa A, et al. Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). FEBS Lett. 1996;396(1):103\u20137.","journal-title":"FEBS Lett."},{"issue":"3","key":"2477_CR14","doi-asserted-by":"publisher","first-page":"H1590","DOI":"10.1152\/ajpheart.00431.2007","volume":"293","author":"DK Singla","year":"2007","unstructured":"Singla DK, McDonald DE. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am J Physiol Heart Circ Physiol. 2007;293(3):H1590\u20135.","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"1","key":"2477_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0303-7207(02)00054-0","volume":"191","author":"MF Smith","year":"2002","unstructured":"Smith MF, Ricke WA, Bakke LJ, Dow MP, Smith GW. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors. Mol Cell Endocrinol. 2002;191(1):45\u201356.","journal-title":"Mol Cell Endocrinol."},{"issue":"3","key":"2477_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/10408360801973244","volume":"45","author":"W Cruz-Munoz","year":"2008","unstructured":"Cruz-Munoz W, Khokha R. The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis. Crit Rev Clin Lab Sci. 2008;45(3):291\u2013338.","journal-title":"Crit Rev Clin Lab Sci."},{"issue":"2","key":"2477_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1023\/A:1006797522521","volume":"18","author":"G Fassina","year":"2000","unstructured":"Fassina G, Ferrari N, Brigati C, Benelli R, Santi L, Noonan DM, et al. Tissue inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis. 2000;18(2):111\u201320.","journal-title":"Clin Exp Metastasis."},{"issue":"1","key":"2477_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1\u20136.","journal-title":"Neoplasia."},{"issue":"W1","key":"2477_CR19","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u2013w60.","journal-title":"Nucleic Acids Res."},{"key":"2477_CR20","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3389\/fgene.2019.01378","volume":"10","author":"H Dong","year":"2019","unstructured":"Dong H, Wang Q, Li N, Lv J, Ge L, Yang M, et al. OSgbm: an online consensus survival analysis web server for glioblastoma. Front Genet. 2019;10:1378.","journal-title":"Front Genet."},{"issue":"D1","key":"2477_CR21","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956\u2013d63.","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2477_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/neuonc\/now247","volume":"19","author":"RL Bowman","year":"2017","unstructured":"Bowman RL, Wang Q, Carro A, Verhaak RG, Squatrito M. GlioVis data portal for visualization and analysis of brain tumor expression datasets. Neuro Oncol. 2017;19(1):139\u201341.","journal-title":"Neuro Oncol."},{"issue":"Web Server issu","key":"2477_CR23","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38(Web Server issue):W214\u201320.","journal-title":"Nucleic Acids Res"},{"key":"2477_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.","journal-title":"BMC Bioinformatics."},{"issue":"W1","key":"2477_CR25","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90\u20137.","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"2477_CR26","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, et al. Gene set knowledge discovery with enrichr. Curr Protoc. 2021;1(3):e90.","journal-title":"Curr Protoc."},{"issue":"21","key":"2477_CR27","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108\u2013e10.","journal-title":"Cancer Res."},{"issue":"19","key":"2477_CR28","doi-asserted-by":"publisher","first-page":"8679","DOI":"10.1158\/0008-5472.CAN-05-1204","volume":"65","author":"M Bredel","year":"2005","unstructured":"Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, et al. Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res. 2005;65(19):8679\u201389.","journal-title":"Cancer Res."},{"issue":"5","key":"2477_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","volume":"9","author":"J Lee","year":"2006","unstructured":"Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006;9(5):391\u2013403.","journal-title":"Cancer Cell."},{"issue":"16","key":"2477_CR30","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.1073\/pnas.0402870102","volume":"102","author":"Y Liang","year":"2005","unstructured":"Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A. 2005;102(16):5814\u20139.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"31","key":"2477_CR31","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1038\/sj.onc.1206753","volume":"22","author":"R Shai","year":"2003","unstructured":"Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, et al. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene. 2003;22(31):4918\u201323.","journal-title":"Oncogene."},{"issue":"18","key":"2477_CR32","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1200\/JCO.2007.15.7164","volume":"26","author":"A Murat","year":"2008","unstructured":"Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, et al. Stem cell-related \u201cself-renewal\u201d signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol. 2008;26(18):3015\u201324.","journal-title":"J Clin Oncol."},{"issue":"4","key":"2477_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ccr.2006.03.003","volume":"9","author":"L Sun","year":"2006","unstructured":"Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell. 2006;9(4):287\u2013300.","journal-title":"Cancer Cell."},{"issue":"1","key":"2477_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2477_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/s12885-018-4589-x","volume":"18","author":"C B\u00f6ckelman","year":"2018","unstructured":"B\u00f6ckelman C, Beilmann-Lehtonen I, Kaprio T, Koskensalo S, Tervahartiala T, Mustonen H, et al. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer. BMC Cancer. 2018;18(1):679.","journal-title":"BMC Cancer."},{"issue":"8","key":"2477_CR36","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00432-013-1453-x","volume":"139","author":"F Ozden","year":"2013","unstructured":"Ozden F, Saygin C, Uzunaslan D, Onal B, Durak H, Aki H. Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival. J Cancer Res Clin Oncol. 2013;139(8):1373\u201382.","journal-title":"J Cancer Res Clin Oncol."},{"issue":"1","key":"2477_CR37","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s12885-020-07150-3","volume":"20","author":"JM Azevedo Martins","year":"2020","unstructured":"Azevedo Martins JM, Rabelo-Santos SH, do Amaral Westin MC, Zeferino LC. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis. BMC Cancer. 2020;20(1):660.","journal-title":"BMC Cancer"},{"issue":"1","key":"2477_CR38","first-page":"1","volume":"34","author":"H Guo","year":"2019","unstructured":"Guo H, Sun Z, Wei J, Xiang Y, Qiu L, Guo L, et al. Expressions of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinase-1 in pituitary adenomas and their relationships with prognosis. Cancer Biother Radiopharm. 2019;34(1):1\u20136.","journal-title":"Cancer Biother Radiopharm."},{"key":"2477_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clineuro.2018.05.001","volume":"170","author":"F Mashayekhi","year":"2018","unstructured":"Mashayekhi F, Saberi A, Mashayekhi S. Serum TIMP1 and TIMP2 concentration in patients with different grades of meningioma. Clin Neurol Neurosurg. 2018;170:84\u20137.","journal-title":"Clin Neurol Neurosurg."},{"issue":"1","key":"2477_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11060-009-9910-8","volume":"95","author":"C Aaberg-Jessen","year":"2009","unstructured":"Aaberg-Jessen C, Christensen K, Offenberg H, Bartels A, Dreehsen T, Hansen S, et al. Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival. J Neurooncol. 2009;95(1):117\u201328.","journal-title":"J Neurooncol."},{"issue":"9","key":"2477_CR41","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/ijc.23337","volume":"122","author":"ZS Wu","year":"2008","unstructured":"Wu ZS, Wu Q, Yang JH, Wang HQ, Ding XD, Yang F, et al. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int J Cancer. 2008;122(9):2050\u20136.","journal-title":"Int J Cancer."},{"issue":"4","key":"2477_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jnci\/86.4.299","volume":"86","author":"R Khokha","year":"1994","unstructured":"Khokha R. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst. 1994;86(4):299\u2013304.","journal-title":"J Natl Cancer Inst."},{"issue":"4893","key":"2477_CR43","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1126\/science.2465572","volume":"243","author":"R Khokha","year":"1989","unstructured":"Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, et al. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science. 1989;243(4893):947\u201350.","journal-title":"Science."},{"issue":"2","key":"2477_CR44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1677\/erc.1.00719","volume":"12","author":"S W\u00fcrtz","year":"2005","unstructured":"W\u00fcrtz S, Schrohl AS, S\u00f8rensen NM, Lademann U, Christensen IJ, Mouridsen H, et al. Tissue inhibitor of metalloproteinases-1 in breast cancer. Endocr Relat Cancer. 2005;12(2):215\u201327.","journal-title":"Endocr Relat Cancer."},{"issue":"8","key":"2477_CR45","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3109\/00365521.2013.812235","volume":"48","author":"M Grunnet","year":"2013","unstructured":"Grunnet M, Mau-S\u00f8rensen M, Br\u00fcnner N. Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review. Scand J Gastroenterol. 2013;48(8):899\u2013905.","journal-title":"Scand J Gastroenterol."},{"issue":"1","key":"2477_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc.2016.115","volume":"17","author":"HW Jackson","year":"2017","unstructured":"Jackson HW, Defamie V, Waterhouse P, Khokha R. TIMPs: versatile extracellular regulators in cancer. Nat Rev Cancer. 2017;17(1):38\u201353.","journal-title":"Nat Rev Cancer."},{"issue":"11","key":"2477_CR47","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/1541-7786.MCR-16-0180","volume":"14","author":"B Gr\u00fcnwald","year":"2016","unstructured":"Gr\u00fcnwald B, Vandooren J, Gerg M, Ahomaa K, Hunger A, Berchtold S, et al. Systemic ablation of MMP-9 triggers invasive growth and metastasis of pancreatic cancer via deregulation of IL6 expression in the bone marrow. Mol Cancer Res. 2016;14(11):1147\u201358.","journal-title":"Mol Cancer Res."},{"issue":"11 Pt A","key":"2477_CR48","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.bbamcr.2017.05.013","volume":"1864","author":"PG Jobin","year":"2017","unstructured":"Jobin PG, Butler GS, Overall CM. New intracellular activities of matrix metalloproteinases shine in the moonlight. Biochim Biophys Acta Mol Cell Res. 2017;1864(11 Pt A):2043\u201355.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2477_CR49","doi-asserted-by":"crossref","unstructured":"Vaitkiene P, Urbanaviciute R, Grigas P, Steponaitis G, Tamasauskas A, Skiriut\u0117 D. Identification of astrocytoma blood serum protein profile. Cells. 2019;9(1).","DOI":"10.3390\/cells9010016"},{"issue":"2","key":"2477_CR50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0092-8674(03)00551-8","volume":"114","author":"DW Seo","year":"2003","unstructured":"Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 2003;114(2):171\u201380.","journal-title":"Cell."},{"key":"2477_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2016.12.001","volume":"39","author":"M Andreucci","year":"2017","unstructured":"Andreucci M, Faga T, Pisani A, Perticone M, Michael A. The ischemic\/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice. Eur J Intern Med. 2017;39:1\u20138.","journal-title":"Eur J Intern Med."},{"issue":"1","key":"2477_CR52","doi-asserted-by":"publisher","first-page":"e0244658","DOI":"10.1371\/journal.pone.0244658","volume":"16","author":"J Waskowski","year":"2021","unstructured":"Waskowski J, Pfortmueller CA, Schenk N, Buehlmann R, Schmidli J, Erdoes G, et al. (TIMP2) x (IGFBP7) as early renal biomarker for the prediction of acute kidney injury in aortic surgery (TIGER). A single center observational study. PLoS One. 2021;16(1):e0244658.","journal-title":"PLoS One"},{"issue":"3","key":"2477_CR53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10555-019-09812-6","volume":"38","author":"C Eckfeld","year":"2019","unstructured":"Eckfeld C, H\u00e4u\u00dfler D, Schoeps B, Hermann CD, Kr\u00fcger A. Functional disparities within the TIMP family in cancer: hints from molecular divergence. Cancer Metastasis Rev. 2019;38(3):469\u201381.","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"2477_CR54","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1038\/s41598-017-03362-z","volume":"7","author":"X Yi","year":"2017","unstructured":"Yi X, Guo J, Guo J, Sun S, Yang P, Wang J, et al. EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion. Sci Rep. 2017;7(1):3568.","journal-title":"Sci Rep."},{"issue":"2","key":"2477_CR55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3233\/CBM-190264","volume":"28","author":"J Lyu","year":"2020","unstructured":"Lyu J, Zhu Y, Zhang Q. An increased level of MiR-222-3p is associated with TMP2 suppression, ERK activation and is associated with metastasis and a poor prognosis in renal clear cell carcinoma. Cancer Biomark. 2020;28(2):141\u20139.","journal-title":"Cancer Biomark."},{"issue":"1","key":"2477_CR56","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1038\/s41598-018-27897-x","volume":"8","author":"W Wang","year":"2018","unstructured":"Wang W, Zhang Y, Liu M, Wang Y, Yang T, Li D, et al. TIMP2 is a poor prognostic factor and predicts metastatic biological behavior in gastric cancer. Sci Rep. 2018;8(1):9629.","journal-title":"Sci Rep."},{"issue":"10","key":"2477_CR57","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1111\/jgh.14660","volume":"34","author":"Z Jin","year":"2019","unstructured":"Jin Z, Zhang G, Liu Y, He Y, Yang C, Du Y, et al. The suppressive role of HYAL1 and HYAL2 in the metastasis of colorectal cancer. J Gastroenterol Hepatol. 2019;34(10):1766\u201376.","journal-title":"J Gastroenterol Hepatol."},{"issue":"11","key":"2477_CR58","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/onc.2014.75","volume":"34","author":"Z Wang","year":"2015","unstructured":"Wang Z, Wang B, Shi Y, Xu C, Xiao HL, Ma LN, et al. Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. Oncogene. 2015;34(11):1407\u201319.","journal-title":"Oncogene."},{"issue":"3","key":"2477_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12032-015-0545-7","volume":"32","author":"PJ Mei","year":"2015","unstructured":"Mei PJ, Chen YS, Du Y, Bai J, Zheng JN. PinX1 inhibits cell proliferation, migration and invasion in glioma cells. Med Oncol. 2015;32(3):73.","journal-title":"Med Oncol."},{"issue":"1","key":"2477_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/labinvest.3700003","volume":"84","author":"KV Lu","year":"2004","unstructured":"Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lab Invest. 2004;84(1):8\u201320.","journal-title":"Lab Invest."},{"key":"2477_CR61","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fphys.2020.00661","volume":"11","author":"D Fan","year":"2020","unstructured":"Fan D, Kassiri Z. Biology of tissue inhibitor of metalloproteinase 3 (TIMP3), and its therapeutic implications in cardiovascular pathology. Front Physiol. 2020;11:661.","journal-title":"Front Physiol."},{"issue":"4","key":"2477_CR62","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/path.1528","volume":"202","author":"PN Span","year":"2004","unstructured":"Span PN, Lindberg RL, Manders P, Tjan-Heijnen VC, Heuvel JJ, Beex LV, et al. Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. J Pathol. 2004;202(4):395\u2013402.","journal-title":"J Pathol."},{"issue":"18","key":"2477_CR63","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1016\/j.ejca.2006.07.003","volume":"42","author":"X Deng","year":"2006","unstructured":"Deng X, Bhagat S, Dong Z, Mullins C, Chinni SR, Cher M. Tissue inhibitor of metalloproteinase-3 induces apoptosis in prostate cancer cells and confers increased sensitivity to paclitaxel. Eur J Cancer. 2006;42(18):3267\u201373.","journal-title":"Eur J Cancer."},{"issue":"11","key":"2477_CR64","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.5858\/arpa.2013-0285-OA","volume":"138","author":"JL Yu","year":"2014","unstructured":"Yu JL, Lv P, Han J, Zhu X, Hong LL, Zhu WY, et al. Methylated TIMP-3 DNA in body fluids is an independent prognostic factor for gastric cancer. Arch Pathol Lab Med. 2014;138(11):1466\u201373.","journal-title":"Arch Pathol Lab Med."},{"issue":"17","key":"2477_CR65","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1128\/MCB.00479-08","volume":"28","author":"G Gabriely","year":"2008","unstructured":"Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol. 2008;28(17):5369\u201380.","journal-title":"Mol Cell Biol."},{"key":"2477_CR66","doi-asserted-by":"crossref","unstructured":"Li W, Du H, Zhou G, Song D. Euxanthone represses the proliferation, migration, and invasion of glioblastoma cells by modulating STAT3\/SHP-1 signaling. Anat Rec. 2020.","DOI":"10.1002\/ar.24363"},{"issue":"4","key":"2477_CR67","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nm846","volume":"9","author":"JH Qi","year":"2003","unstructured":"Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med. 2003;9(4):407\u201315.","journal-title":"Nat Med."},{"issue":"9-10","key":"2477_CR68","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/sj.bjc.6690217","volume":"79","author":"AH Baker","year":"1999","unstructured":"Baker AH, George SJ, Zaltsman AB, Murphy G, Newby AC. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer. 1999;79(9-10):1347\u201355.","journal-title":"Br J Cancer."},{"issue":"1","key":"2477_CR69","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/jcp.21919","volume":"222","author":"GS Winkler","year":"2010","unstructured":"Winkler GS. The mammalian anti-proliferative BTG\/Tob protein family. J Cell Physiol. 2010;222(1):66\u201372.","journal-title":"J Cell Physiol."},{"issue":"8","key":"2477_CR70","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/jcb.25110","volume":"116","author":"H Shen","year":"2015","unstructured":"Shen H, Li W, Tian Y, Xu P, Wang H, Zhang J, et al. Upregulation of miR-362-3p modulates proliferation and anchorage-independent growth by directly targeting Tob2 in hepatocellular carcinoma. J Cell Biochem. 2015;116(8):1563\u201373.","journal-title":"J Cell Biochem."},{"issue":"5","key":"2477_CR71","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3892\/mmr.2017.6289","volume":"15","author":"Y Lin","year":"2017","unstructured":"Lin Y, Zhao J, Wang H, Cao J, Nie Y. miR-181a modulates proliferation, migration and autophagy in AGS gastric cancer cells and downregulates MTMR3. Mol Med Rep. 2017;15(5):2451\u20136.","journal-title":"Mol Med Rep."},{"key":"2477_CR72","doi-asserted-by":"publisher","first-page":"11650","DOI":"10.1038\/srep11650","volume":"5","author":"Y Gong","year":"2015","unstructured":"Gong Y, He T, Yang L, Yang G, Chen Y, Zhang X. The role of miR-100 in regulating apoptosis of breast cancer cells. Sci Rep. 2015;5:11650.","journal-title":"Sci Rep."},{"issue":"13","key":"2477_CR73","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1111\/febs.14824","volume":"286","author":"Y Yan","year":"2019","unstructured":"Yan Y, Yan H, Wang Q, Zhang L, Liu Y, Yu H. MicroRNA 10a induces glioma tumorigenesis by targeting myotubularin-related protein 3 and regulating the Wnt\/\u03b2-catenin signaling pathway. FEBS J. 2019;286(13):2577\u201392.","journal-title":"FEBS J."},{"issue":"4","key":"2477_CR74","doi-asserted-by":"publisher","first-page":"e0123352","DOI":"10.1371\/journal.pone.0123352","volume":"10","author":"A Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez A, Ses\u00e9 M, Losa JH, Robichaud N, Sonenberg N, Aasen T, et al. Phosphorylation of eIF4E confers resistance to cellular stress and DNA-damaging agents through an interaction with 4E-T: a rationale for novel therapeutic approaches. PLoS One. 2015;10(4):e0123352.","journal-title":"PLoS One."},{"issue":"12","key":"2477_CR75","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1093\/emboj\/19.12.3142","volume":"19","author":"J Dostie","year":"2000","unstructured":"Dostie J, Ferraiuolo M, Pause A, Adam SA, Sonenberg N. A novel shuttling protein, 4E-T, mediates the nuclear import of the mRNA 5\u2019 cap-binding protein, eIF4E. EMBO J. 2000;19(12):3142\u201356.","journal-title":"EMBO J."},{"issue":"11-12","key":"2477_CR76","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1101\/gad.336073.119","volume":"34","author":"F R\u00e4sch","year":"2020","unstructured":"R\u00e4sch F, Weber R, Izaurralde E, Igreja C. 4E-T-bound mRNAs are stored in a silenced and deadenylated form. Genes Dev. 2020;34(11-12):847\u201360.","journal-title":"Genes Dev."},{"key":"2477_CR77","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1476-4598-7-85","volume":"7","author":"J Melendez-Zajgla","year":"2008","unstructured":"Melendez-Zajgla J, Del Pozo L, Ceballos G, Maldonado V. Tissue inhibitor of metalloproteinases-4. The road less traveled. Mol Cancer. 2008;7:85.","journal-title":"Mol Cancer"},{"issue":"15","key":"2477_CR78","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/S0959-8049(01)00215-5","volume":"37","author":"T Hagemann","year":"2001","unstructured":"Hagemann T, Gunawan B, Schulz M, F\u00fczesi L, Binder C. mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas. Eur J Cancer. 2001;37(15):1839\u201346.","journal-title":"Eur J Cancer."},{"issue":"23","key":"2477_CR79","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1038\/sj.onc.1201245","volume":"14","author":"M Wang","year":"1997","unstructured":"Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM, et al. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene. 1997;14(23):2767\u201374.","journal-title":"Oncogene."},{"issue":"6","key":"2477_CR80","first-page":"2365","volume":"61","author":"Y Jiang","year":"2001","unstructured":"Jiang Y, Wang M, Celiker MY, Liu YE, Sang QX, Goldberg ID, et al. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res. 2001;61(6):2365\u201370.","journal-title":"Cancer Res."},{"issue":"6","key":"2477_CR81","doi-asserted-by":"publisher","first-page":"896","DOI":"10.4161\/epi.28601","volume":"9","author":"YW Zhang","year":"2014","unstructured":"Zhang YW, Zheng Y, Wang JZ, Lu XX, Wang Z, Chen LB, et al. Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer. Epigenetics. 2014;9(6):896\u2013909.","journal-title":"Epigenetics."},{"issue":"10","key":"2477_CR82","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/carcin\/bgz023","volume":"40","author":"M Shrestha","year":"2019","unstructured":"Shrestha M, Ando T, Chea C, Sakamoto S, Nishisaka T, Ogawa I, et al. The transition of tissue inhibitor of metalloproteinases from -4 to -1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP\/TAZ activation. Carcinogenesis. 2019;40(10):1288\u201397.","journal-title":"Carcinogenesis."},{"issue":"3","key":"2477_CR83","doi-asserted-by":"publisher","first-page":"853","DOI":"10.7150\/thno.29553","volume":"9","author":"M Miyake","year":"2019","unstructured":"Miyake M, Furuya H, Onishi S, Hokutan K, Anai S, Chan O, et al. Monoclonal antibody against CXCL1 (HL2401) as a novel agent in suppressing IL6 expression and tumoral growth. Theranostics. 2019;9(3):853\u201367.","journal-title":"Theranostics."},{"issue":"5-8","key":"2477_CR84","doi-asserted-by":"publisher","first-page":"151046","DOI":"10.1016\/j.ejcb.2019.151046","volume":"98","author":"R Solga","year":"2019","unstructured":"Solga R, Behrens J, Ziemann A, Riou A, Berwanger C, Becker L, et al. CRN2 binds to TIMP4 and MMP14 and promotes perivascular invasion of glioblastoma cells. Eur J Cell Biol. 2019;98(5-8):151046.","journal-title":"Eur J Cell Biol."},{"issue":"10","key":"2477_CR85","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/modpathol.2010.136","volume":"23","author":"S Rorive","year":"2010","unstructured":"Rorive S, Lopez XM, Maris C, Trepant AL, Sauvage S, Sadeghi N, et al. TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas. Mod Pathol. 2010;23(10):1418\u201328.","journal-title":"Mod Pathol."},{"issue":"3","key":"2477_CR86","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11060-011-0691-5","volume":"106","author":"NA Pullen","year":"2012","unstructured":"Pullen NA, Anand M, Cooper PS, Fillmore HL. Matrix metalloproteinase-1 expression enhances tumorigenicity as well as tumor-related angiogenesis and is inversely associated with TIMP-4 expression in a model of glioblastoma. J Neurooncol. 2012;106(3):461\u201371.","journal-title":"J Neurooncol."},{"key":"2477_CR87","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.2147\/CMAR.S179762","volume":"11","author":"B Gu","year":"2019","unstructured":"Gu B, Li M, Zhang Y, Li L, Yao K, Wang S. DR7 encoded by human herpesvirus 6 promotes glioma development and progression. Cancer Manag Res. 2019;11:2109\u201318.","journal-title":"Cancer Manag Res."},{"issue":"1","key":"2477_CR88","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jdsr.2017.10.001","volume":"54","author":"N Chosa","year":"2018","unstructured":"Chosa N, Ishisaki A. Two novel mechanisms for maintenance of stemness in mesenchymal stem cells: SCRG1\/BST1 axis and cell-cell adhesion through N-cadherin. Jpn Dent Sci Rev. 2018;54(1):37\u201344.","journal-title":"Jpn Dent Sci Rev."},{"issue":"1","key":"2477_CR89","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1460-9568.2005.04172.x","volume":"22","author":"M Dron","year":"2005","unstructured":"Dron M, Bailly Y, Beringue V, Haeberl\u00e9 AM, Griffond B, Risold PY, et al. Scrg1 is induced in TSE and brain injuries, and associated with autophagy. Eur J Neurosci. 2005;22(1):133\u201346.","journal-title":"Eur J Neurosci."},{"issue":"1","key":"2477_CR90","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4161\/auto.2228","volume":"2","author":"M Dron","year":"2006","unstructured":"Dron M, Bailly Y, Beringue V, Haeberl\u00e9 AM, Griffond B, Risold PY, et al. SCRG1, a potential marker of autophagy in transmissible spongiform encephalopathies. Autophagy. 2006;2(1):58\u201360.","journal-title":"Autophagy."},{"key":"2477_CR91","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.coph.2021.03.001","volume":"58","author":"M Abdollahi Nejat","year":"2021","unstructured":"Abdollahi Nejat M, Klaassen RV, Spijker S, Smit AB. Auxiliary subunits of the AMPA receptor: The Shisa family of proteins. Curr Opin Pharmacol. 2021;58:52\u201361.","journal-title":"Curr Opin Pharmacol."},{"issue":"41","key":"2477_CR92","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1038\/onc.2017.181","volume":"36","author":"P Mu","year":"2017","unstructured":"Mu P, Akashi T, Lu F, Kishida S, Kadomatsu K. A novel nuclear complex of DRR1, F-actin and COMMD1 involved in NF-\u03baB degradation and cell growth suppression in neuroblastoma. Oncogene. 2017;36(41):5745\u201356.","journal-title":"Oncogene."},{"key":"2477_CR93","doi-asserted-by":"publisher","first-page":"251398","DOI":"10.1155\/2013\/251398","volume":"2013","author":"JR Fern\u00e1ndez Mass\u00f3","year":"2013","unstructured":"Fern\u00e1ndez Mass\u00f3 JR, Oliva Arg\u00fcelles B, Tejeda Y, Astrada S, Garay H, Reyes O, et al. The antitumor peptide CIGB-552 increases COMMD1 and inhibits growth of human lung cancer cells. J Amino Acids. 2013;2013:251398.","journal-title":"J Amino Acids."},{"issue":"4","key":"2477_CR94","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA Cancer J Clin. 2020;70(4):299\u2013312.","journal-title":"CA Cancer J Clin."},{"issue":"3","key":"2477_CR95","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","volume":"164","author":"M Ceccarelli","year":"2016","unstructured":"Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell. 2016;164(3):550\u201363.","journal-title":"Cell."},{"issue":"2","key":"2477_CR96","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155(2):462\u201377.","journal-title":"Cell."},{"issue":"10","key":"2477_CR97","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997\u20131003.","journal-title":"N Engl J Med."},{"issue":"8","key":"2477_CR98","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/annonc\/mdz164","volume":"30","author":"BW Kristensen","year":"2019","unstructured":"Kristensen BW, Priesterbach-Ackley LP, Petersen JK, Wesseling P. Molecular pathology of tumors of the central nervous system. Ann Oncol. 2019;30(8):1265\u201378.","journal-title":"Ann Oncol."},{"issue":"1","key":"2477_CR99","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98\u2013110.","journal-title":"Cancer Cell."},{"issue":"18","key":"2477_CR100","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557\u201366.","journal-title":"Cancer Res."},{"key":"2477_CR101","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","volume":"387","author":"T Wu","year":"2017","unstructured":"Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61\u20138.","journal-title":"Cancer Lett."},{"key":"2477_CR102","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, et al. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126\u201333.","journal-title":"Cancer Lett."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02477-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T14:29:05Z","timestamp":1714746545000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02477-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2477"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02477-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"assertion":[{"value":"31 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests associated with the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"447"}}